SCHEMBL5128535

SCHEMBL5128535

O=C1NC(=S)S/C1=C/c1ccc(-c2cccc(Cl)c2Cl)o1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 4/20 0.82
INSR P06213 3/20 0.82
SIRT2 Q8IXJ6 2/20 0.67
SIRT1 Q96EB6 2/20 0.67
SIRT5 Q9NXA8 2/20 0.67
PIK3CG P48736 7/20 0.65
PTP4A3 O75365 1/20 0.64
GSK3A P49840 3/20 0.63
GSK3B P49841 3/20 0.63
MEN1 O00255 1/20 0.63
ALDH1A1 P00352 1/20 0.63
LMNA P02545 1/20 0.63
POLB P06746 1/20 0.63
MAPT P10636 1/20 0.63
HPGD P15428 1/20 0.63
MAPK1 P28482 1/20 0.63
HTT P42858 1/20 0.63
RECQL P46063 1/20 0.63
KMT2A Q03164 1/20 0.63
MCL1 Q07820 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5128536 1.00 IGF1R (0.82) IGF1RINSRSIRT2SIRT1SIRT5
SCHEMBL14277837 1.00 IGF1R (0.82) IGF1RINSRSIRT2SIRT1SIRT5
SCHEMBL623774 0.90 IGF1R (1.00) IGF1RINSRPIK3CGPTP4A3GSK3A
SCHEMBL623775 0.90 IGF1R (1.00) IGF1RINSRPIK3CGPTP4A3GSK3A
SCHEMBL623776 0.90 IGF1R (1.00) IGF1RINSRPIK3CGPTP4A3GSK3A
SCHEMBL3890812 0.81 IGF1R (0.74) IGF1RINSRPIK3CGPTP4A3GSK3A
SCHEMBL3890807 0.81 IGF1R (0.74) IGF1RINSRPIK3CGPTP4A3GSK3A
SCHEMBL13236142 0.81 IGF1R (0.74) IGF1RINSRPIK3CGPTP4A3GSK3A
SCHEMBL6090652 0.81 IGF1R (0.74) IGF1RINSRPIK3CGPTP4A3GSK3A
SCHEMBL622800 0.81 PIK3CG (0.80) IGF1RINSRPIK3CGPTP4A3GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051445-A1 2-Thioxothiazolidin-4-one compounds and compositions as antimicrobial and antimalarial agents targeting enoyl-ACP reductase of type II fatty acid synthesis pathway and other cell growth pathways NATIONAL INSTITUTE OF IMMUNOLOGY. 2008-02-28 US disclosed
EP-1834642-A2 2-thioxothiazolidin-4-one compounds and compositions as antimicrobial and antimalarial agents targeting enoyl-ACP reductase of type II fatty acid synthesis pathway and other cell growth pathways National Institute of Immunology (IN) 2007-09-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051445-A1 2-Thioxothiazolidin-4-one compounds and compositions as antimicrobial and antimalarial agents targeting enoyl-ACP reductase of type II fatty acid synthesis pathway and other cell growth pathways FASN, FADS2, TECR IGF1R 3557/4885INSR 2530/4885SIRT2 623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.